A new structural blueprint paves the way for improved targeting of cancer cells, particularly those with BRCA1 and BRCA2 ...
DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers ...
Scientists at Scripps Research have now captured the first detailed images of the DNA repair protein, Pol-theta, in action, ...
Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.
Technically, Pol-theta is an enzyme—a type of protein that speeds up chemical ... but some cancers—particularly those arising from BRCA1 or BRCA2 mutations, such as certain breast and ovarian ...
Tango Therapeutics, Inc.’s TNGX share price has surged by 13.59%, which has investors questioning if this is right time to ...
Discover 7 biotech companies in Taiwan, a rising regional player in precision medicine, immunotherapy, and drug development!
DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long ...
Women with a BRCA1 or BRCA2 mutation have up to a 72% chance of breast cancer during their lifetime. Normally, the PALB2 gene makes a protein that works with the BRCA2 gene protein to repair ...